#btig

United Therapeutics Drops 5.2% Despite BTIG Buy Rating

United Therapeutics shares fell 5.2% Friday as BTIG upgraded to buy with $728 target.

Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m